Ligand-Controlled Regioselective Deuteration of Indoles: Anti-C3 Selectivity and Mechanistic Insights
Organic Letters · 22.05.2026 · 28 (20) · 6460-6467
DOI: 10.1021/acs.orglett.6c01618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 08.05.2026. Verfasst von Shuaizhong Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gannan Medical University, Ganzhou 341000, China. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Gannan Medical University, Ganzhou 341000, China.
- Ganzhou People's Hospital, Ganzhou 341000, China.
- School of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou 450001, China.
- School of Pharmacy, Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Jiangxi Provincial Key Laboratory of Tissue Engineering, Gannan Medical University, Ganzhou 341000, China.
ORCID-Profile: Feng Jiang, Jinquan Zhang
Förderung
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Zhang, S., Chen, L., Su, Z., Gu, D., Chen, Y., Lv, Q., Jiang, F., & Zhang, J. (2026). Ligand-Controlled Regioselective Deuteration of Indoles: Anti-C3 Selectivity and Mechanistic Insights. Organic Letters, 28(20), 6460-6467. https://doi.org/10.1021/acs.orglett.6c01618
Vancouver
Zhang S, Chen L, Su Z, Gu D, Chen Y, Lv Q, et al. Ligand-Controlled Regioselective Deuteration of Indoles: Anti-C3 Selectivity and Mechanistic Insights. Organic Letters. 2026;28(20):6460-6467. doi:10.1021/acs.orglett.6c01618
BibTeX
@article{Zhang2026,
author = {Zhang, Shuaizhong and Chen, Liping and Su, Zhuanzhuan and Gu, Defa and Chen, Youwen and Lv, Qiujie and Jiang, Feng and Zhang, Jinquan},
title = {Ligand-Controlled Regioselective Deuteration of Indoles: Anti-C3 Selectivity and Mechanistic Insights},
journal = {Organic Letters},
year = {2026},
volume = {28},
number = {20},
pages = {6460--6467},
doi = {10.1021/acs.orglett.6c01618}
}
EUVIMED